NO155842C - Analogifremgangsmaate ved fremstilling av terapeutiske aktive 2-beta-d-ribofuranosylselenazol-4-carboxamider. - Google Patents
Analogifremgangsmaate ved fremstilling av terapeutiske aktive 2-beta-d-ribofuranosylselenazol-4-carboxamider.Info
- Publication number
- NO155842C NO155842C NO831012A NO831012A NO155842C NO 155842 C NO155842 C NO 155842C NO 831012 A NO831012 A NO 831012A NO 831012 A NO831012 A NO 831012A NO 155842 C NO155842 C NO 155842C
- Authority
- NO
- Norway
- Prior art keywords
- ribofuranosylselenazole
- carboxamides
- beta
- preparation
- therapeutic active
- Prior art date
Links
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D421/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms
- C07D421/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms containing two hetero rings
- C07D421/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/20—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36096882A | 1982-03-23 | 1982-03-23 | |
US06/465,221 US4531001A (en) | 1982-03-23 | 1983-02-15 | 2-β-D-ribofuranosylselenazole-4-carboxamide compounds |
Publications (3)
Publication Number | Publication Date |
---|---|
NO831012L NO831012L (no) | 1983-09-26 |
NO155842B NO155842B (no) | 1987-03-02 |
NO155842C true NO155842C (no) | 1987-06-10 |
Family
ID=27001098
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO831012A NO155842C (no) | 1982-03-23 | 1983-03-22 | Analogifremgangsmaate ved fremstilling av terapeutiske aktive 2-beta-d-ribofuranosylselenazol-4-carboxamider. |
Country Status (14)
Country | Link |
---|---|
US (1) | US4531001A (da) |
EP (1) | EP0089678B1 (da) |
KR (1) | KR880001869B1 (da) |
AU (1) | AU553665B2 (da) |
CA (1) | CA1209986A (da) |
DE (1) | DE3366378D1 (da) |
DK (2) | DK167765B1 (da) |
ES (5) | ES520826A0 (da) |
FI (1) | FI76574C (da) |
GR (1) | GR78301B (da) |
IE (1) | IE54520B1 (da) |
NO (1) | NO155842C (da) |
NZ (1) | NZ203649A (da) |
PT (1) | PT76426B (da) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4619996A (en) * | 1984-07-09 | 1986-10-28 | Warner-Lambert Company | Process for preparing 2-β-D-ribofuranosylselenazole-4-carboxamide |
US4801698A (en) * | 1986-08-15 | 1989-01-31 | Warner-Lambert Company | Process for preparing diaminopyrimido(4,5-d)pyrimidine glycoside and glycotide |
US5438131A (en) * | 1992-09-16 | 1995-08-01 | Bergstrom; Donald E. | 3-nitropyrrole nucleoside |
GB9307043D0 (en) * | 1993-04-05 | 1993-05-26 | Norsk Hydro As | Chemical compounds |
US5907036A (en) * | 1995-02-17 | 1999-05-25 | Icn Pharmaceuticals, Inc. | Procedures for obtaining ribo-C-nucleosides |
IL132737A0 (en) * | 1997-06-30 | 2001-03-19 | Icn Pharmaceuticals | Method of producing tiazofurin and other c-nucleosides |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3423399A (en) * | 1966-06-09 | 1969-01-21 | Takeda Chemical Industries Ltd | Method for the production of 5'-ribonucleotide |
US3798209A (en) * | 1971-06-01 | 1974-03-19 | Icn Pharmaceuticals | 1,2,4-triazole nucleosides |
US3984396A (en) * | 1971-06-01 | 1976-10-05 | Icn Pharmaceuticals, Inc. | 1-(β,-D-ribofuranosyl)-1,2,4-triazole acid esters |
-
1983
- 1983-02-15 US US06/465,221 patent/US4531001A/en not_active Expired - Fee Related
- 1983-03-18 IE IE580/83A patent/IE54520B1/en not_active IP Right Cessation
- 1983-03-22 NO NO831012A patent/NO155842C/no unknown
- 1983-03-22 FI FI830941A patent/FI76574C/fi not_active IP Right Cessation
- 1983-03-22 ES ES520826A patent/ES520826A0/es active Granted
- 1983-03-22 DK DK129983A patent/DK167765B1/da not_active IP Right Cessation
- 1983-03-22 EP EP83102841A patent/EP0089678B1/en not_active Expired
- 1983-03-22 NZ NZ203694A patent/NZ203649A/xx unknown
- 1983-03-22 GR GR70837A patent/GR78301B/el unknown
- 1983-03-22 PT PT76426A patent/PT76426B/pt not_active IP Right Cessation
- 1983-03-22 KR KR1019830001203A patent/KR880001869B1/ko not_active IP Right Cessation
- 1983-03-22 AU AU12693/83A patent/AU553665B2/en not_active Expired
- 1983-03-22 CA CA000424166A patent/CA1209986A/en not_active Expired
- 1983-03-22 DE DE8383102841T patent/DE3366378D1/de not_active Expired
- 1983-11-15 ES ES527277A patent/ES8600322A1/es not_active Expired
- 1983-11-15 ES ES527276A patent/ES8600321A1/es not_active Expired
- 1983-11-15 ES ES527279A patent/ES8600323A1/es not_active Expired
- 1983-11-15 ES ES527278A patent/ES527278A0/es active Granted
-
1993
- 1993-03-08 DK DK025093A patent/DK172165B1/da not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO161002C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive polypeptider. | |
NO160521C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 13alfa- alkylgonaner. | |
NO156785C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive cyklobutan-derivater. | |
NO150760C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive aminotiazoler. | |
NO812344L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive steroider. | |
NO810675L (no) | Fremgangsmaate ved fremstilling av terapeutisk aktive tetrazolderivater. | |
NO161317C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive oksikamer. | |
NO163693C (no) | Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser av platina. | |
NO154492C (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme forbindelser. | |
NO158460C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive forbindelser. | |
NO814055L (no) | Fremgangsmaate ved fremstilling av terapeutisk aktive thienopyridinonderivater | |
NO159528C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive aminoguanidinderivater. | |
NO157976C (no) | Analogifremgangsm te ved fremstilling av terapeutisk aktive 3-fenoxy-1-azetidincarboxamider. | |
NO165400C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive cefemforbindelser. | |
NO162817C (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme 4-aryl-4-piperidin-carbinoler. | |
NO880667L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive arylpiperazinyl-alkylen-fenyl-heterocykliske forbindelser. | |
NO811346L (no) | Fremgangsmaate ved fremstilling av terapeutisk aktive adenosin-derivater. | |
NO873680D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive sulfonamido-etyl-forbindelser. | |
NO159090C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridoindol-derivater. | |
NO164899C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylindolforbindelser. | |
NO158800C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive indenderivater. | |
NO156167C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive indolinon-derivater. | |
NO163570C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive acylaminomitosaner. | |
NO162188C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinoliner. | |
NO155842C (no) | Analogifremgangsmaate ved fremstilling av terapeutiske aktive 2-beta-d-ribofuranosylselenazol-4-carboxamider. |